Li, W. F., Song, J., Zhang, X., Du, S., Ezhilarasu, P., Yoshino, T., Li, Y., Alvarez, J. G. B. (2026). Cost-effectiveness analysis of teclistamab plus daratumumab in relapsed or refractory multiple myeloma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11038